Skip to main content
Top
Published in: Clinical Rheumatology 9/2018

01-09-2018 | Original Article

Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample

Authors: Yunkyung Kim, Jihun Kang, Geun-Tae Kim

Published in: Clinical Rheumatology | Issue 9/2018

Login to get access

Abstract

Hyperuricemia is not only a risk factor for gout but also an independent determinant of hypertension, diabetes, and chronic kidney diseases. Although the incidence of gout in Korean adults is increasing, epidemiologic studies on hyperuricemia in the general Korean population are limited. Thus, this study aimed at evaluating the prevalence of hyperuricemia and its associated factors among non-institutionalized Korean adults. The present study included 5548 participants (2403 men and 3145 women) aged ≥ 19 years from The Korea National Health and Nutrition Examination Survey. Based on the new 2016 census data, the age-standardized prevalence and mean uric acid level were calculated using the chi-square test and t test, respectively. A multivariate logistic regression analysis was performed to evaluate the risk factors associated with hyperuricemia. The age-standardized prevalence of hyperuricemia and mean uric acid level in the general Korean population was 11.4% (17.0% in men and 5.9% in women) and 5.1 mg/dL (5.83 mg/dL in men and 4.36 mg/dL in women), respectively. The prevalence of hyperuricemia was high in young Korean adults, and a U-shaped association was observed between hyperuricemia and age. While obesity, metabolic syndrome, renal impairment, and low-grade inflammation were positively associated with hyperuricemia in both sexes, alcohol consumption, education, and current smoking status had a positive association with hyperuricemia only in women. Hyperuricemia is prevalent in the young population in Korea, and special efforts are necessary to reduce the potential harmful effects of hyperuricemia on the health of adults, particularly the younger-generation adults, in Korea.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649–662CrossRefPubMed Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649–662CrossRefPubMed
2.
go back to reference Kuwabara M, Niwa K, Nishi Y, Mizuno A, Asano T, Masuda K, Komatsu I, Yamazoe M, Takahashi O, Hisatome I (2014) Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res 37:785–789CrossRefPubMed Kuwabara M, Niwa K, Nishi Y, Mizuno A, Asano T, Masuda K, Komatsu I, Yamazoe M, Takahashi O, Hisatome I (2014) Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res 37:785–789CrossRefPubMed
3.
go back to reference Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC (2008) High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31:361–362CrossRefPubMed Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC (2008) High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31:361–362CrossRefPubMed
4.
go back to reference Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P (2014) Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies. BMC Nephrol 15:122CrossRefPubMedPubMedCentral Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P (2014) Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies. BMC Nephrol 15:122CrossRefPubMedPubMedCentral
5.
go back to reference Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH (2009) Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 61:225–232CrossRefPubMed Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH (2009) Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 61:225–232CrossRefPubMed
6.
go back to reference Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheumatol 63:3136–3141CrossRef Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheumatol 63:3136–3141CrossRef
7.
go back to reference Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP (2012) Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis-2011-201254 Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP (2012) Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis-2011-201254
8.
go back to reference Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, Gow PJ, Harrison AA, Highton J, Jones PB (2009) Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case–control sample sets. Arthritis Rheum 60:3485–3492CrossRefPubMed Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, Gow PJ, Harrison AA, Highton J, Jones PB (2009) Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case–control sample sets. Arthritis Rheum 60:3485–3492CrossRefPubMed
9.
go back to reference Cheng LS-C, Chiang S-L, Tu H-P, Chang S-J, Wang T-N, Ko AM-J, Chakraborty R, Ko Y-C (2004) Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am J Hum Genet 75:498–503CrossRefPubMed Cheng LS-C, Chiang S-L, Tu H-P, Chang S-J, Wang T-N, Ko AM-J, Chakraborty R, Ko Y-C (2004) Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am J Hum Genet 75:498–503CrossRefPubMed
10.
go back to reference Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M (2014) Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis-2014-206410 Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M (2014) Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis-2014-206410
11.
go back to reference Yu S, Yang H, Guo X, Zhang X, Zhou Y, Ou Q, Zheng L, Sun Y (2016) Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin Rheumatol 35:1207–1215CrossRefPubMed Yu S, Yang H, Guo X, Zhang X, Zhou Y, Ou Q, Zheng L, Sun Y (2016) Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin Rheumatol 35:1207–1215CrossRefPubMed
12.
go back to reference Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 350:1093–1103CrossRefPubMed Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 350:1093–1103CrossRefPubMed
14.
go back to reference Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62:170–180 Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62:170–180
15.
go back to reference Chuang S-Y, Lee S-C, Hsieh Y-T, Pan W-H (2011) Trends in hyperuricemia and gout prevalence: nutrition and health survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 20:301–308PubMed Chuang S-Y, Lee S-C, Hsieh Y-T, Pan W-H (2011) Trends in hyperuricemia and gout prevalence: nutrition and health survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 20:301–308PubMed
16.
go back to reference Kim J-W, Kwak SG, Lee H, Kim S-K, Choe J-Y, Park S-H (2017) Prevalence and incidence of gout in Korea: data from the national health claims database 2007–2015. Rheumatol Int 37:1499–1506CrossRefPubMed Kim J-W, Kwak SG, Lee H, Kim S-K, Choe J-Y, Park S-H (2017) Prevalence and incidence of gout in Korea: data from the national health claims database 2007–2015. Rheumatol Int 37:1499–1506CrossRefPubMed
17.
go back to reference Lee CH, Sung NY (2011) The prevalence and features of Korean gout patients using the National Health Insurance Corporation database. J Rheum Dis 18:94–100CrossRef Lee CH, Sung NY (2011) The prevalence and features of Korean gout patients using the National Health Insurance Corporation database. J Rheum Dis 18:94–100CrossRef
18.
go back to reference Ryu S, Chang Y, Zhang Y, Kim S-G, Cho J, Son HJ, Shin H, Guallar E (2012) A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol 175:133–143CrossRefPubMed Ryu S, Chang Y, Zhang Y, Kim S-G, Cho J, Son HJ, Shin H, Guallar E (2012) A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol 175:133–143CrossRefPubMed
19.
go back to reference Kweon S, Kim Y, M-j J, Kim Y, Kim K, Choi S, Chun C, Khang Y-H, Oh K (2014) Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol 43:69–77CrossRefPubMedPubMedCentral Kweon S, Kim Y, M-j J, Kim Y, Kim K, Choi S, Chun C, Khang Y-H, Oh K (2014) Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol 43:69–77CrossRefPubMedPubMedCentral
20.
go back to reference Armstrong T, Bull F (2006) Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health 14:66–70CrossRef Armstrong T, Bull F (2006) Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health 14:66–70CrossRef
21.
go back to reference Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75:72–80CrossRefPubMed Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75:72–80CrossRefPubMed
22.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
23.
go back to reference Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640–1645CrossRefPubMed Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640–1645CrossRefPubMed
24.
go back to reference Uaratanawong S, Suraamornkul S, Angkeaw S, Uaratanawong R (2011) Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol 30:887–893CrossRefPubMed Uaratanawong S, Suraamornkul S, Angkeaw S, Uaratanawong R (2011) Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol 30:887–893CrossRefPubMed
25.
go back to reference Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 27:227–233CrossRefPubMed Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 27:227–233CrossRefPubMed
26.
go back to reference Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69:928–933CrossRefPubMed Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69:928–933CrossRefPubMed
27.
go back to reference Yang J, Liu Z, Zhang C, Zhao Y, Sun S, Wang S, Zhao Y, Zhang Y, Li J, Lu F (2013) The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan. Rheumatol Int 33:1511–1517CrossRefPubMed Yang J, Liu Z, Zhang C, Zhao Y, Sun S, Wang S, Zhao Y, Zhang Y, Li J, Lu F (2013) The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan. Rheumatol Int 33:1511–1517CrossRefPubMed
28.
go back to reference Chen S-Y, Chen C-L, Shen M-L, Kamatani N (2003) Trends in the manifestations of gout in Taiwan. Rheumatology 42:1529–1533CrossRefPubMed Chen S-Y, Chen C-L, Shen M-L, Kamatani N (2003) Trends in the manifestations of gout in Taiwan. Rheumatology 42:1529–1533CrossRefPubMed
29.
30.
go back to reference Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, Saito S, Komatsu K, Takashina K, Takada G (2006) Serum uric acid as an obesity-related indicator in early adolescence. Tohoku J Exp Med 209:257–262CrossRefPubMed Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, Saito S, Komatsu K, Takashina K, Takada G (2006) Serum uric acid as an obesity-related indicator in early adolescence. Tohoku J Exp Med 209:257–262CrossRefPubMed
31.
go back to reference Khang Y-H, Yun S-C (2010) Trends in general and abdominal obesity among Korean adults: findings from 1998, 2001, 2005, and 2007 Korea National Health and Nutrition Examination Surveys. J Korean Med Sci 25:1582–1588CrossRefPubMedPubMedCentral Khang Y-H, Yun S-C (2010) Trends in general and abdominal obesity among Korean adults: findings from 1998, 2001, 2005, and 2007 Korea National Health and Nutrition Examination Surveys. J Korean Med Sci 25:1582–1588CrossRefPubMedPubMedCentral
32.
go back to reference Park HS, Oh SW, Cho S-I, Choi WH, Kim YS (2004) The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 33:328–336CrossRefPubMed Park HS, Oh SW, Cho S-I, Choi WH, Kim YS (2004) The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 33:328–336CrossRefPubMed
34.
go back to reference Liu H, Zhang X-M, Wang Y-L, Liu B-C (2014) Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol 27:653–658CrossRefPubMed Liu H, Zhang X-M, Wang Y-L, Liu B-C (2014) Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol 27:653–658CrossRefPubMed
35.
go back to reference Lim S, Jang H, Lee H, Kimm K, Park C, Cho N (2006) A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: the Korean Health and Genome tudy (KHGS). J Endocrinol Investig 29:313–319CrossRef Lim S, Jang H, Lee H, Kimm K, Park C, Cho N (2006) A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: the Korean Health and Genome tudy (KHGS). J Endocrinol Investig 29:313–319CrossRef
36.
go back to reference Kim S, Lee J, Lee J, Na J, Han J, Yoon D, Baik S, Choi D, Choi K (2006) Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care 29:226–231CrossRefPubMed Kim S, Lee J, Lee J, Na J, Han J, Yoon D, Baik S, Choi D, Choi K (2006) Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care 29:226–231CrossRefPubMed
37.
go back to reference Liu L, Lou S, Xu K, Meng Z, Zhang Q, Song K (2013) Relationship between lifestyle choices and hyperuricemia in Chinese men and women. Clin Rheumatol 32:233–239CrossRefPubMed Liu L, Lou S, Xu K, Meng Z, Zhang Q, Song K (2013) Relationship between lifestyle choices and hyperuricemia in Chinese men and women. Clin Rheumatol 32:233–239CrossRefPubMed
38.
go back to reference Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281CrossRefPubMed Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281CrossRefPubMed
39.
go back to reference Faller J, Fox IH (1982) Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med 307:1598–1602CrossRefPubMed Faller J, Fox IH (1982) Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med 307:1598–1602CrossRefPubMed
40.
go back to reference Brand F, McGee D, Kannel W, STOKES III J, Castelli W (1985) Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 121:11–18CrossRefPubMed Brand F, McGee D, Kannel W, STOKES III J, Castelli W (1985) Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 121:11–18CrossRefPubMed
41.
go back to reference Villegas R, Xiang Y-B, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO (2010) Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord 8:263–270CrossRefPubMedPubMedCentral Villegas R, Xiang Y-B, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO (2010) Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord 8:263–270CrossRefPubMedPubMedCentral
42.
go back to reference Yu M-A, Sanchez-Lozada LG, Johnson RJ, Kang D-H (2010) Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 28:1234–1242PubMed Yu M-A, Sanchez-Lozada LG, Johnson RJ, Kang D-H (2010) Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 28:1234–1242PubMed
43.
go back to reference Kang D-H, Park S-K, Lee I-K, Johnson RJ (2005) Uric acid–induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562CrossRefPubMed Kang D-H, Park S-K, Lee I-K, Johnson RJ (2005) Uric acid–induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562CrossRefPubMed
44.
go back to reference Marangella M (2005) Uric acid elimination in the urine. In: Hyperuricemic syndromes: pathophysiology and therapy, Vol. 147. Karger publishers, pp 132–148 Marangella M (2005) Uric acid elimination in the urine. In: Hyperuricemic syndromes: pathophysiology and therapy, Vol. 147. Karger publishers, pp 132–148
45.
go back to reference Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Smith GD, Lawlor DA, Timpson NJ (2013) Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ 347:f4262CrossRefPubMedPubMedCentral Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Smith GD, Lawlor DA, Timpson NJ (2013) Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ 347:f4262CrossRefPubMedPubMedCentral
46.
go back to reference Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 44:527–536CrossRefPubMed Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 44:527–536CrossRefPubMed
47.
go back to reference Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J (2006) The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 33:1346–1350PubMed Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J (2006) The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 33:1346–1350PubMed
Metadata
Title
Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample
Authors
Yunkyung Kim
Jihun Kang
Geun-Tae Kim
Publication date
01-09-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4130-2

Other articles of this Issue 9/2018

Clinical Rheumatology 9/2018 Go to the issue

Case Based Review

Some days you win

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.